Drug profile · INN
levofloxacin
QUINSAIR
- US status
- approved
- Patents linked
- 1
- News articles
- 0
Quick answer
levofloxacin (QUINSAIR) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH. Route of administration: ophthalmic. Current US regulatory status: approved.
Key facts
INN levofloxacin
Brand QUINSAIR
Route OPHTHALMIC
Formulation INJECTABLE
ATC code J01MA12
Originator Teva Pharma GmbH
Related patents
Search patents →Frequently asked questions
What is levofloxacin?
levofloxacin (QUINSAIR) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH. Route of administration: ophthalmic. Current US regulatory status: approved.
What is the brand name for levofloxacin?
QUINSAIR is a marketed brand name for levofloxacin. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of levofloxacin?
levofloxacin has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.